It would be nice to get some good news for a change. Taci failures, analyst downgrades, law suits and management lowing the price of their options was not good for the stock price. If you add up the valus of the various compounds, ZGEN should be valued at least 3x the current value. If management can not get the full value an acquisition may be the only answer. If I were the head of BMS, I would buy the whole company, it would cost less than they have agreed to pay to develop Lambda.